Adaling Ogilvie

2.1k total citations
57 papers, 1.8k citations indexed

About

Adaling Ogilvie is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Adaling Ogilvie has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Physiology and 9 papers in Surgery. Recurrent topics in Adaling Ogilvie's work include Adenosine and Purinergic Signaling (27 papers), RNA and protein synthesis mechanisms (9 papers) and Neurological Complications and Syndromes (6 papers). Adaling Ogilvie is often cited by papers focused on Adenosine and Purinergic Signaling (27 papers), RNA and protein synthesis mechanisms (9 papers) and Neurological Complications and Syndromes (6 papers). Adaling Ogilvie collaborates with scholars based in Germany, Austria and Kazakhstan. Adaling Ogilvie's co-authors include Jürgen Lüthje, Eckhard Schulze-Lohoff, Ulrich Pohl, Rudi Busse, R. Bernd Sterzel, Gerold Schuler, K Wiebauer, W. Kersten, J. R. Kalden and Alexandra Ogilvie and has published in prestigious journals such as Journal of Biological Chemistry, Biomaterials and Analytical Biochemistry.

In The Last Decade

Adaling Ogilvie

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adaling Ogilvie Germany 28 1.1k 681 290 232 166 57 1.8k
Adrien R. Beaudoin Canada 20 911 0.8× 724 1.1× 108 0.4× 153 0.7× 235 1.4× 45 1.9k
Katarzyna Koziak Poland 19 904 0.8× 462 0.7× 143 0.5× 251 1.1× 114 0.7× 40 1.7k
Józef Spychała United States 17 880 0.8× 722 1.1× 117 0.4× 181 0.8× 67 0.4× 36 1.6k
Kristen K. Skarratt Australia 19 1.0k 0.9× 303 0.4× 190 0.7× 411 1.8× 90 0.5× 31 1.6k
Maryse Picher United States 21 793 0.7× 459 0.7× 87 0.3× 58 0.3× 215 1.3× 37 1.7k
Jin Ren United States 23 562 0.5× 791 1.2× 95 0.3× 593 2.6× 122 0.7× 45 1.9k
Silvia M. Kreda United States 24 534 0.5× 1.2k 1.8× 51 0.2× 164 0.7× 360 2.2× 44 2.9k
Sergey Apasov United States 24 2.1k 1.9× 902 1.3× 140 0.5× 1.6k 7.0× 154 0.9× 29 3.6k
Amy M.L. Ng Canada 25 1.5k 1.4× 812 1.2× 137 0.5× 46 0.2× 60 0.4× 42 2.6k

Countries citing papers authored by Adaling Ogilvie

Since Specialization
Citations

This map shows the geographic impact of Adaling Ogilvie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adaling Ogilvie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adaling Ogilvie more than expected).

Fields of papers citing papers by Adaling Ogilvie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adaling Ogilvie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adaling Ogilvie. The network helps show where Adaling Ogilvie may publish in the future.

Co-authorship network of co-authors of Adaling Ogilvie

This figure shows the co-authorship network connecting the top 25 collaborators of Adaling Ogilvie. A scholar is included among the top collaborators of Adaling Ogilvie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adaling Ogilvie. Adaling Ogilvie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogilvie, Alexandra, et al.. (2008). Cell Death Induced by Uridine 5'-triphosphate (UTP) in Contrast to Adenosine 5'-triphosphate (ATP) in Human Epidermoid Carcinoma Cells (A-431). Cellular Physiology and Biochemistry. 22(5-6). 441–454. 10 indexed citations
2.
Pfister, Martín, et al.. (2001). NAD degradation and regulation of CD38 expression by human monocytes/macrophages. European Journal of Biochemistry. 268(21). 5601–5608. 3 indexed citations
3.
Ogilvie, Adaling, et al.. (2001). NAD degradation and regulation of CD38 expression by human monocytes/macrophages. European Journal of Biochemistry. 268(21). 5601–5608. 33 indexed citations
4.
Ogilvie, Adaling, Christian Antoni, Claudia Dechant, et al.. (2001). Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. British Journal of Dermatology. 144(3). 587–589. 113 indexed citations
5.
Schneider, C., Heinz Wiendl, & Adaling Ogilvie. (2001). Biphasic cytotoxic mechanism of extracellular ATP on U-937 human histiocytic leukemia cells: involvement of adenosine generation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1538(2-3). 190–205. 32 indexed citations
6.
Ogilvie, Adaling, et al.. (1998). The response of peritoneal macrophages after implantation of several ceramics as measured by the change of ectoenzyme activity. Biomaterials. 19(11-12). 1049–1055. 3 indexed citations
7.
Ogilvie, Adaling, et al.. (1995). Silencing of the epidermal growth factor receptor in the absence of the ligand requires phospholipase C activity. FEBS Letters. 372(2-3). 173–176. 11 indexed citations
8.
Schulze-Lohoff, Eckhard, et al.. (1995). Extracellular ATP augments mesangial cell growth induced by multiple growth factors. Nephrology Dialysis Transplantation. 10(11). 2027–2034. 17 indexed citations
9.
Davids, Eugen & Adaling Ogilvie. (1995). Differences in distribution and synthesis of the functional opponents 245-1245-1245-1inhibitor and neutrophil elastase in eukaryotic cells. Histochemistry and Cell Biology. 104(3). 245–253. 3 indexed citations
10.
Ringkamp, Matthias, et al.. (1994). Activated human platelets in plasma excite nociceptors in rat skin, in vitro. Neuroscience Letters. 170(1). 103–106. 29 indexed citations
12.
Lüthje, Jürgen, et al.. (1988). Levels of 5'-nucleotide phosphodiesterase isoenzymes in normal and pathological sera. Clinica Chimica Acta. 177(2). 131–139. 5 indexed citations
13.
Lüthje, Jürgen, A. Schomburg, & Adaling Ogilvie. (1988). Demonstration of a novel ecto‐enzyme on human erythrocytes, capable of degrading ADP and of inhibiting ADP‐induced platelet aggregation. European Journal of Biochemistry. 175(2). 285–289. 45 indexed citations
14.
Ogilvie, Adaling, et al.. (1987). Unproportionally high concentrations of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) in heavy platelets. Annals of Hematology. 54(4). 193–200. 22 indexed citations
15.
Lüthje, Jürgen & Adaling Ogilvie. (1987). 5'-Nucleotide phosphodiesterase isoenzymes in human serum: Quantitative measurement and some biochemical properties. Clinica Chimica Acta. 164(3). 275–284. 13 indexed citations
16.
Lüthje, Jürgen & Adaling Ogilvie. (1987). Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterization. European Journal of Biochemistry. 169(2). 385–388. 35 indexed citations
17.
Ogilvie, Adaling, et al.. (1985). Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood. Annals of Hematology. 51(6). 405–413. 29 indexed citations
18.
Maubach, P., Bertold Emmerich, Andreas Willer, Adaling Ogilvie, & Johann Rastetter. (1984). Urinary glycoproteins in acute leukemias: a 41000 dalton glycoprotein follows the kinetic of cytoreduction. Annals of Hematology. 48(4). 243–246. 4 indexed citations
19.
Ogilvie, Adaling, et al.. (1975). Quinone induced stringent control. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 395(2). 136–145. 13 indexed citations
20.
Ogilvie, Adaling, K Wiebauer, & W. Kersten. (1975). Stringent control of ribonucleic acid synthesis in Bacillus subtilis treated with granaticin. Biochemical Journal. 152(3). 517–522. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026